In Boston, when someone says life sciences, what you generally think of is therapeutic development. Therapeutic development gets all the large funding rounds, the press coverage, etc. But there is a second life sciences industry in development. This is medical data science, the application of data science techniques such as machine learning and deep learning applied to biometric data. We can use these techniques to better understand the complex system that is our bodies and their basic biological function. More than genomics, we can measure how the body responds to medication in near real time with the advancement of medical wearables creating co-diagnostics, novel endpoints for clinical trials, and truly personalized medicine.
Presenter: Dan Morden, CEO, Stealth Venture